Bayes-Genis A, Aimo A, Lupon J. Empagliflozin in heart failure with preserved and mildly reduced ejection fraction: prognostic benefit confirmed with different endpoint definitions. Eur J Heart Fail 2022 Jul 4. doi: 10.1002/ejhf.2597.
PMID: 35781908